Stigma against mental illness is a complex construct with affective, cognitive, and behavioral
components. Beyond its symbolic value, federal law can only directly address one …

Objective: The purpose of this study was to provide updated national estimates and
correlates of service use, unmet need, and barriers to mental health treatment among adults …

Background: Buprenorphine has been proven effective in treating opioid use disorder.
However, the high cost of buprenorphine and the limited prescribing capacity may restrict …

This study examines reasons why people do not seek help for alcohol or drug problems by
gender and race/ethnicity using data from the National Epidemiologic Survey on Alcohol …

Individuals with co-occurring serious mental illness and substance use disorders experience
a highly fragmented system of care, contributing to poor health outcomes and elevated …

The Affordable Care Act requires state Medicaid programs to cover substance use disorder
treatment for their Medicaid expansion population but allows states to decide which …

Objective: Little is known about the effect recent health care reform legislation will have on
coverage of individuals with severe mental disorders. The authors examined current and …

Background and aims Uncertainty about optimal treatment duration for buprenorphine
opioid agonist therapy may lead to substantial variation in provider and payer decision …

Care Act)(PL 111-148) will generate sweeping changes in the financing, organization, and
accessibility of health and social services in the United States. The expansion of Medicaid …

The Impact of Insurance Coverage in Diminishing Racial and Ethnic Disparities in Behavioral
Health Services - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …